JGIA
BIIB icon

Jackson Grant Investment Advisers’s Biogen BIIB Stock Holding History

Jackson Grant Investment Advisers’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-55
Closed -$13K – 226
2019
Q1 		$13K Sell
55
-77
-58% -$24.2K 0.01% 198
2018
Q4 		$40K Buy
+132
New +$42.1K 0.03% 153

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jackson Grant Investment Advisers's BIIB Position: Q2 2019 in Review

Jackson Grant Investment Advisers sold out of Biogen (BIIB) in Q2 2019, closing a stake of 55 shares — an estimated $13K sold.

Jackson Grant Investment Advisers first reported a position in BIIB in Q4 2018 and held it in 2 quarters. The position peaked at $40K in Q4 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Jackson Grant Investment Advisers reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Jackson Grant Investment Advisers sold 55 Biogen shares in Q2 2019, an estimated $13K.
  • Jackson Grant Investment Advisers first reported a position in Biogen in Q4 2018 and held it in 2 quarters.
  • Jackson Grant Investment Advisers's Biogen position peaked at $40K in Q4 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2019, filed 13 Aug 2019.